The U.S. Food and Drug Administration (FDA) has taken an unprecedented step by authorizing the marketing of four Glas e-cigarettes, including the following pod flavors: Classic Menthol, Fresh Menthol, ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac ...

Digitoxin in addition to guideline-directed medical therapy, reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and ...

This page features ACC's full meeting coverage of the latest science from ACC.25 – including trial summaries, news stories, journal scans, videos and more.

Until about 15 years ago, most cardiologists were found in private practices, where the physicians – usually in groups – owned the practice and had privileges for hospital-based services at one or ...

The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) proposed rule, updating the PFS conversion factor from $32.3465 to $33.5875 for ...

As obesity continues to drive cardiovascular risk, the ACC has released two new guidance documents to support clinicians: Concise Clinical Guidance (CCG) on the medical management of obesity and a ...

Medical coding translates health care services into standardized codes (such as CPT, ICD-10-CM, HCPCS) for insurance billing, directly determining physician reimbursement based on documentation.

This page features ACC's full meeting coverage of the latest science from the American College of Cardiology's Annual Scientific Session & Expo 2023 Together With WCC (ACC.23/WCC) – including trial ...

This concise, point-of-care tool outlines recommended vaccines and key considerations for patients with cardiovascular disease. For easy reference, it distills and supports recommendations set forth ...

Endovascular therapy added to standard care for post-thrombotic syndrome was associated with improved syndrome severity and quality of life (QOL) at six months compared with standard care alone in ...

In the first year of its approval in the U.S., transcatheter tricuspid valve replacement (TTVR) in patients with severe tricuspid regurgitation (TR) was found to be safe and effective by STS/ACC TVT ...